Highlights:

• Skin Elements marks a performance-packed March 2022 quarter with several key developments.
• SKN delivered the first order of 86,040 units of SuprCuvr worth AU$1.1 million under Pacific Health Care Distribution Agreement.
• SKN is aiming to produce 100,000 litres/day of SuprCuvr to meet growing demand for the disinfectant.

The award-winning skin care company, Skin Elements (ASX:SKN) wrapped up the March 2022 quarter with flying colours, thanks to the overriding success of its flagship product SuprCuvr - the world’s first and the only approved disinfectant with an efficacy of 99.99999% (7 log reduction) against COVID 19 in independent laboratory testing.

SKN has been marching ahead with the development of natural and organic health care products with an innovative approach to plant-based and organic ingredients. Its exclusive portfolio of products is sold and distributed in the global market.

The product range includes the TGA-registered SuprCuvr, Invisi Shield alcohol free natural sanitiser, Soléo Organics natural and organic sunscreen, PapayaActivs natural therapeutics skincare and Elizabeth Jane Natural Cosmetics brand.

Image source: Company website

Do read: Skin Elements (ASX:SKN) enhancing health & wellness, naturally

Here’s a quick rundown of the developments that took place during the quarter ending 31 March 2022!

• SKN executed an exclusive Distribution Agreement with Pacific Health Care Pty Ltd expanding distribution channels for SuprCuvr in Australia and New Zealand. The company delivered first order of 120,200 litres of SuprCuvr in 86,040 units with sales value of AU$1.1 million during the quarter. SuprCuvr is now stocked up in 168 IGA and 15 Good Grocer IGA supermarkets across Western Australia. During the March quarter alone, the company completed invoicing for sales worth AU$1,140,504.

Over the duration of the agreement, Pacific Health has the potential to deal with total sales volumes of 5.5692M litres of SuprCuvr.

Read: Skin Elements (ASX:SKN) delivers first AU$1.1M SuprCuvr order

• SKN is taking essential measures to boost product manufacturing, taking into account the probable growth in demand for SuprCuvr in times ahead. SKN recently acquired manufacturing and ingredients supply chain facilities which can produce 100,000 litres/day of SuprCuvr. Also, the company is planning to get additional batching facilities to stay certain about uninterrupted supply and sale of SuprCuvr products via digital platforms - Pacific Health Care (www.pacifichealthcare.com.au) and SKN’s online store (sknlife.com.au.).

• SKN and LDA Capital entered into an equity funding facility agreement. Following the terms of the agreement, LDA Capital will provide Skin Elements with up to AU$20 million in committed equity capital over a period of three years.

Interesting read: A Glance Through Skin Elements’ All-Natural Soléo Organics Sunscreen

Also read: Meet the SKN stalwarts at the helm of Invisi Shield® development

Stock information: SKN stock was trading at AU$0.036 on the Australian Securities Exchange (ASX), with a market capitalisation of AU$14.29 million, as on 04 May 2022.